FDA
-
-
-
-
-
-
-
eGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies
-
-
-
-
-
-
-
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy
-
-
-
-
-
-
-
Eledon Pharmaceuticals (ELDN) Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Pancreatic Islet Cell Transplantation
-
-
-
-
-
-
-
Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results
-
-
-
-
-
-
-
Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
-
-
251,890 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All